from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/34fihim on October 31, 2019 at 12:14PM
The House on Monday, Oct. 28, unanimously passed the Public Disclosure of Drug Discounts Act in a bid to boost transparency in how drugmakers price their drugs, One America News Network reports.
The bill now goes to the Senate for full approval.
“Patients who are being pitched these medicines and being asked to go talk to their doctor about these drugs, that while they currently get the medical efficacy and safety concern information in the ADs, they’re not being told the price of the very medicine they’re being asked to have a discussion about,” Health and Human Services Secretary Alex Azar said.
To read the full report, click here.